NFAT2 Regulates Generation of Innate-Like CD8+ T Lymphocytes and CD8+ T Lymphocytes Responses by Emilia Pachulec et al.
October 2016 | Volume 7 | Article 4111
Original research
published: 06 October 2016
doi: 10.3389/fimmu.2016.00411
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Loretta Tuosto, 
Sapienza University of Rome, Italy
Reviewed by: 
Francesca Granucci, 
University of Milano-Bicocca, Italy  
Sho Yamasaki, 
Kyushu University, Japan  
Avery August, 
Cornell University, USA
*Correspondence:
João P. B. Viola  
jpviola@inca.gov.br
Specialty section: 
This article was submitted 
to T Cell Biology, 
a section of the journal 
Frontiers in Immunology
Received: 26 May 2016
Accepted: 22 September 2016
Published: 06 October 2016
Citation: 
Pachulec E, Neitzke-Montinelli V and 
Viola JPB (2016) NFAT2 Regulates 
Generation of Innate-Like CD8+ 
T Lymphocytes and CD8+ 
T Lymphocytes Responses. 
Front. Immunol. 7:411. 
doi: 10.3389/fimmu.2016.00411
nFaT2 regulates generation of 
innate-like cD8+ T lymphocytes and 
cD8+ T lymphocytes responses
Emilia Pachulec, Vanessa Neitzke-Montinelli and João P. B. Viola*
Program of Cellular Biology, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
Nuclear factor of activated T cells (NFAT) 2 null mutant mice die in utero of cardiac failure, 
precluding analysis of the role of NFAT2 in lymphocyte responses. Only the NFAT2 −/−/
Rag-1−/− chimeric mice model gave insight into the role of NFAT2 transcription factor in 
T lymphocyte development, activation, and differentiation. As reports are mainly focused 
on the role of NFAT2 in CD4+ T lymphocytes activation and differentiation, we decided 
to investigate NFAT2’s impact on CD8+ T lymphocyte responses. We report that NFAT2 
is phosphorylated and inactive in the cytoplasm of naive CD8+ T cells, and upon TCR 
stimulation, it is dephosphorylated and translocated into the nucleus. To study the role of 
NFAT2 in CD8+ T responses, we employed NFAT2fl/flCD4-Cre mice with NFAT2 deletion 
specifically in T cells. Interestingly, the absence of NFAT2 in T cells resulted in increased 
percentage of non-conventional innate-like CD8+ T cells. These cells were CD122+, rapid 
producer of interferon gamma (IFN-γ) and had characteristics of conventional memory 
CD8+ T cells. We also observed an expansion of PLZF+ expressing CD3+ thymocyte 
population in the absence of NFAT2 and increased IL-4 production. Furthermore, we 
found that CD8+ T lymphocytes deficient in NFAT2 had reduced activation, proliferation, 
and IFN-γ and IL-2 production at suboptimal TCR strength. NFAT2 absence did not sig-
nificantly influence differentiation of CD8+ T cells into cytotoxic effector cells but reduced 
their IFN-γ production. This work documents NFAT2 as a negative regulator of innate-like 
CD8+ T cells development. NFAT2 is required for complete CD8+ T cell responses at 
suboptimal TCR stimulation and regulates IFN-γ production by cytotoxic CD8+ T cells 
in vitro.
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inTrODUcTiOn
CD8+ T cells are the key mediators in cell-mediated immunity against intracellular bacteria, viral 
infections, and tumor cells. Conventional CD8+ T cells develop in the thymus from a bone marrow-
derived multipotent T cells progenitor through a series of defined and coordinated developmental 
stages of differentiation, positive and negative selection, and maturation. Mature single positive 
(SP) CD8+ T cells leave the thymus and migrate to peripheral lymphoid organs. In the peripheral 
lymphoid organs, naive CD8+ T cells, which are activated by specific antigens, differentiate into 
effector T cells that are able to kill target cells through the release of cytotoxic granules, secretion 
of cytokines, such as interferon gamma (IFN-γ) and Fas/FasL-dependent pathway. A small number 
of activated CD8+ T cells develop into memory T cells that provide long-term protection against 
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reinfection (1). There are several subsets of memory CD8+ 
T cells, and among them, central and effector memory T cells (2). 
Central memory T cells express high level of CD62L and reside 
mainly in peripheral lymphoid organs, whereas effector memory 
T cells express low level of CD62L and are present mainly in non-
lymphoid tissues. The development of effector or memory CD8+ 
T cells is dependent on the environment created by the innate 
immune system, for example, the presence of cytokines such as 
IL-12 promoting effector CD8+ T cells differentiation (3) or IL-7 
and IL-15 required for the maintenance and survival of memory 
CD8+ T cells (4).
In addition to conventional CD8+ T cells, there are also several 
subsets of CD8+ T cells that acquire functions as a result of their 
maturation process rather than through antigen activation. These 
cells are believed to be selected by hematopoietic cells and are 
dependent on signals transduced through signaling lymphocyte 
activation molecule (SLAM) family members (5, 6). A subset of 
these cells, called memory-like or innate-like T cells, has been 
described in a few gene knockout animal models (5–14) and 
humans (15). These cells share characteristics with conventional 
memory CD8+ T cells, such as high expression of CD44 and 
CD122 (5, 6), and with innate cells as they can rapidly secrete 
IFN-γ upon stimulation (16). It has been reported that memory-
like CD8+ T cells play important roles in the innate response 
against infections such as Listeria monocytogenes, chronic infec-
tions with viruses such as Herpes virus (17–19), and tumor cell 
lines in vitro (20).
Nuclear factor of activated T cells (NFAT) was originally 
described as a transcription factor inducing the expression of 
interleukin 2 (IL-2) (21). The NFAT family of transcription factors 
consists of five members, named NFAT1–5, and the main forms 
expressed in T cells are NFAT1 and NFAT2 (22). NFAT1 is con-
stitutively expressed in T cells (23), whereas NFAT2 is induced 
upon T-cell receptor stimulation (24). NFAT proteins reside 
phosphorylated in the cytoplasm. In activated lymphocytes, 
NFAT is dephosphorylated by calcineurin (25–28), translocates 
from the cytoplasm into the nucleus (29–31), where coupled 
with other transcription factors (26, 32) binds to the promotor 
regions of multiple genes to induce their transcription. Previous 
studies showed that NFAT proteins play regulatory roles during 
T-cell differentiation and effector functions. NFAT1 deficiency in 
T cells diminished Th1 differentiation and induced IL-4 pro-
duction (33). NFAT1 was also reported to contribute to IL-21 
expression and to limit the immunosuppressive function of 
CD4+CD25+Foxp3+GITR+ T regulatory (Treg) cells (34).
The role of NFAT2 in T-cell differentiation is not fully under-
stood, as the total inactivation of NFAT2 gene in mice led to an 
early death of mice embryos (35). Previous analysis on Th1- and 
Th2-skewed T cells isolated from NFAT2−/−/Rag-1−/− chimeric 
mice revealed an involvement of NFAT2 in the induction of the 
Th2-cytokines IL-4 and IL-6, whereas it had no effect on IFN-γ 
and IL-2 expression in Th1 cells (36–38). NFAT2 binding sites 
were found within the Il17a promoter (39) and the Il10 promoter 
(40). Recently, NFAT2 has been shown as a positive regulator of 
RORγT and Th17 cytokines during TGF-β-mediated Th17-cell 
differentiation (41). NFAT2-deficient TGF-β-induced iTreg 
cells showed a slight reduction of CD25 and Foxp3 expression 
as compared to WT cells (42), indicating no essential role for 
NFAT2 in iTreg cell development. Up to now, most of the available 
studies are focused on the role of NFAT2 in CD4+ T lymphocytes 
differentiation and little is known about its function in CD8+ T 
lymphocytes responses.
In this study, we analyzed the role of NFAT2 in CD8+ T cell 
development and differentiation with the help of conditional 
NFAT2-deficient mice that were generated by crossing NFAT2fl/fl 
mice to CD4-Cre mice. These mice show a functional NFAT2 
deficiency beyond double positive (DP) thymocytes, conse-
quently CD8+ mature T cells. Our results indicate that NFAT2 
plays an important role in the development of innate-like CD8+ 
T cells in the thymus. We further demonstrate that conditional 
inactivation of NFAT2 in T cells alter the threshold of CD8+ 
T cell activation, proliferation, and cytokines production but not 
differentiation. NFAT2 is not essential for differentiation into 
effector CD8+ T lymphocytes in vitro; however, it is important 
for IFN-γ production by cytotoxic CD8+ T cells.
MaTerials anD MeThODs
animals
C57BL/6 and NFAT2fl/flCD4-Cre were bred and maintained at 
the Brazilian National Cancer Institute (INCA) animal facility 
(Rio de Janeiro, RJ, Brazil). Also, 6- to 12-week-old mice were 
used in all experiments. NFAT2fl/flCD4-Cre mice were generated 
in Dr. Anjana Rao’s laboratory (La Jolla Institute for Allergy and 
Immunology, San Diego, CA, USA). All animal experiments 
were performed in accordance with the Brazilian Government’s 
ethical and animal experimental regulations. The experiments 
were approved and conducted according to the animal welfare 
guidelines of the Ethics Committee of Animal Experimentation 
from INCA (CEUA process no. 004/13).
cell culture
Primary cells were cultured in DMEM supplemented with 10% 
FCS, l-glutamine, streptomycin–penicillin, essential and non-
essential amino acids, vitamins, HEPES, and 2-ME (all from 
Gibco) in a humidified environment containing 5% CO2 at 37°C. 
P815 cell line was cultured in RPMI supplemented with 10% 
FCS, l-glutamine, streptomycin–penicillin, sodium pyruvate, 
and 2-ME (all from Gibco). CD8+ T cells were purified from total 
lymph nodes (inguinal, brachial, and axillary). Cells were isolated 
with Dynal Mouse CD8 Negative Isolation Kit (Invitrogen). For 
cytometric purity analysis, cells were stained with anti-CD4-PE 
and anti-CD8-FITC Abs (both from BD Pharmingen) and ana-
lyzed by flow cytometry on a FACScan (BD Biosciences). Cell 
populations were isolated to >95% purity. Total lymph nodes or 
purified CD8+ T lymphocytes were activated in vitro for indicated 
times with plate-bound anti-CD3 (1  μg/ml; BD Pharmingen; 
otherwise indicated) plus soluble anti-CD28 (1  μg/ml; BD 
Pharmingen). To differentiate CD8+ T lymphocytes into cytotoxic 
CD8+T lymphocytes in vitro, 1 × 106 cells were activated for 48 h 
with plate-bound anti-CD3 (1  μg/ml) plus soluble anti-CD28 
(1 μg/ml). Cells were expanded daily for 4 days with 200 U/ml of 
murine recombinant IL-2 (43). At day 5, cells were analyzed by 
flow cytometry and in cytotoxicity assay in vitro.
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cytoplasmic and nuclear Protein 
extraction
Purified CD8+ T lymphocytes (3 × 106) were stimulated or left 
untreated for indicated times with plate-bound anti-CD3 plus 
soluble anti-CD28 (both at 1  μg/ml). To extract cytoplasmic 
fraction, cells were lysed in buffer containing 10 mM Tris-Cl pH 
7.5, 10 mM NaCl, 3 mM MgCl2, 0.5 mM DTT, 0.1 mM EDTA, 
0.5% NP-40, 1  mM PMSF, and protease inhibitor. Nuclear 
extracts were obtained by lysis of the nuclei with buffer con-
taining 40 mM Tris-Cl pH 7.5, 10 mM EDTA, 60 mM sodium 
pyrophosphate, and 5% SDS followed by incubation at 100°C 
for 15 min.
Western Blot
Total protein extract from 3 × 106 T lymphocytes was obtained 
from cells lysis in buffer containing 40 mM Tris pH 7.5, 60 mM 
sodium pyrophosphate, 10 mM EDTA, and 5% SDS, followed by 
incubation at 100°C for 15 min. Total cell lysates were resolved 
by SDS-PAGE, and the separated proteins were transferred onto 
a nitrocellulose membrane. The antibodies used were GAPDH 
monoclonal antibody 6C5 (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) and NFAT2 monoclonal antibody 7A6 (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA). The immunodetec-
tion was performed with the ECL Western Blotting Detection Kit 
(GE Healthcare).
immunofluorescence
Intracellular localization of NFAT2 protein was analyzed in 
purified CD8+ T cells (5  ×  105 cells) from C57BL/6 mice by 
immunofluorescence staining. Briefly, cells were stimulated or 
left unstimulated for indicated time with plate-bound anti-CD3 
plus soluble anti-CD28 (both at 1 μg/ml). Then, cells were fixed in 
4% paraformaldehyde, permeabilized with 0.5% Non-idet P-40, 
and stained with anti-NFAT2 Ab. The cells were photographed 
with Confocal Laser Scanning Microscope FV10i-O Olympus.
Flow cytometry
To analyze cell surface expression levels of the various markers, 
the cell suspensions (1 × 106) were incubated with following mAbs: 
anti-CD3-APC, anti-B220-FITC, anti-CD4-PE, anti-CD4-FITC, 
anti-CD8-FITC, anti-NK1.1-PerCP.Cy5.5, anti-PLZF-PE, anti-
CD44-FITC, anti-CD69-APC, anti-CD62L-PE, anti-CD62L-
PerCP, anti-CD25-APC, anti-CD122-PE, and anti-CD127-PE 
(all BD Pharmingen) acquired in a FACScan (Becton Dickinson, 
Mountain View, CA, USA) and analyzed using FlowJo software.
intracellular staining
For intracellular cytokine staining, 1 × 106 cells were stimulated 
in vitro for 6 h with PMA (10 nM) plus ionomycine (1 μM, both 
from Calbiochem). Brefeldin A (1:1000; BD Pharmingen) was 
added to the culture for last 2 h. Cells were harvested and stained 
with anti-CD8-FITC Abs. Then, cells were fixed, permeabilized, 
and stained with anti-IFN-γ-FITC, anti-IL-2-PE, anti-IL-4-APC, 
and anti-Granzime B-FITC Abs. For PLZF intracellular staining, 
cells were harvested and stained with anti-CD3-APC, fixed, 
permeablized, and stained with anti-PLZF-PE. Samples were 
analyzed by flow cytometry on a FACScan (BD Biosciences) and 
FlowJo software.
Proliferation assay
Purified CD8+ T lymphocytes (5 × 106) were stained with CFSE 
Cell Proliferation Assay (Invitrogen) according to manufac-
turer’s instructions, then stimulated or not with plate-bound 
anti-CD3 (0.25  μg/ml) plus soluble anti-CD28 (1  μg/ml) for 
indicated times in the absence or presence of 200 U/ml of IL-2. 
Carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution 
was analyzed by flow cytometry on FACScan (BD Biosciences) 
and FlowJo Software.
rna extractions and real-time rT-Pcr
Total RNA from total or sorted into CD44low and CD44high 
naive CD8+ T lymphocytes, total thymocytes, CD4+ thymo-
cytes, and total splenocytes was extracted using Trizol LS 
Reagent (Invitrogen), and first-strand cDNA was synthesized 
using ImProm-II Reverse Transcription System (Promega) 
or Superscript II kit (Life Technology) for sorted CD44low and 
CD44high CD8+ T lymphocytes and CD4+ thymocytes. Real-
time polymerase chain reactions for NFAT2 and PLZF were 
performed using SYBR Green master mix (Applied Biosystems) 
and for Blimp-1, Tbx21, IL-4, Eomes using Taqman probes. 
Actin or HPRT were used as endogenous control. Sequences 
of primers used for SyberGreen real-time PCR are NFAT2-F 
5′-CCAGAAAATAACATGCGAGCC-3′, NFAT2-R 5′-GTGG 
GATGTGAACTCGGAAG-3′, PLZF-F 5′-GAGCAGTGCAGCG 
TGTGT-3′, and PLZF-R 5′-AACCGTTTTCCGCAGAGTT-3′ 
(44), Actin-F 5′-ATGGTGGGAATGGGTCAGAAG-3′, Actin-R 
5′-TTCTCCATGTCGTCCCAGTTG-3′. All procedures were 
performed according to the manufacturers’ instructions.
In Vitro cytotoxicity assay
Target cells (P815) at 106/ml were labeled with 10-μM Calcein-AM 
(Molecular Probes) in complete medium for 30  min at 37°C. 
The assay was performed in V bottom 96-well microtiter plates 
with E:T ratios ranging from 2:1 to 0.5:1 with wells for spon-
taneous (only target cells in complete medium) and maximum 
release (only target cells in medium plus 2% Triton X-100) in 
the presence of 1 μg/ml of soluble anti-CD3, in triplicate. Each 
well contained from 1 × 105 to 2.5 × 104 lymphocytes in 100 μl 
of complete medium and 5 × 104 target cells/50 μl of complete 
medium. After incubation at 37°C in 5% CO2 for 4 h, 75 μl of 
each supernatant was harvested and transferred into new plates. 
Samples were measured using a Spectramax Gemini dual-
scanning microplate spectrofluorimeter (Molecular Devices) 
(excitation: 485  nm; emission: 530). Data were expressed as 
arbitrary fluorescent units (AFU). Percent lysis was calculated 
with the following formula: [(A sample  −  A spontaneous)/ 
(A max − A spontaneous)] × 100.
statistical analysis
For single comparisons, unpaired Student’s t-test was used. Flow 
cytometry and mean fluorescence intensity analysis was per-
formed using FlowJo 10.1r5 software and analyzed for statistical 
significance by unpaired two-tailed Student’s t-test using Prism 
FigUre 1 | nFaT2 is present and functional in cD8+ T lymphocytes. CD8+ T lymphocytes were purified from naive C57BL/6 mice, as described, and then left 
unstimulated (0) or stimulated in vitro with anti-CD3 plus anti-CD28 (both at 1 μg/ml) for indicated times. (a) Total RNA was isolated, and NFAT2 mRNA levels were 
analyzed by real-time RT-PCR assay using SYBR green master mix. The data are normalized to the β-actin levels. Data are shown as mean ± SD of three 
independent experiments. Detection of NFAT2 transcription factor in CD8+ T cells in total lysates (B) and in cytoplasmic and nuclear fractions (c) by Western blot. 
(D) Cellular localization of NFAT2 protein in CD8+ T cells by immunofluorescence staining. All data are representative of at least two independent experiments.
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(GraphPad Software). Differences with p < 0.05 were considered 
statistically significant.
resUlTs
nFaT2 is Present and Functional in cD8+ 
T lymphocytes
TCR stimulation results in calcium mobilization and consequent 
activation of NFAT transcription factors. NFAT is activated by 
the phosphatase calcineurin, which dephosphorylates multiple 
phosphoserines in the regulatory domain of NFAT, leading to 
NFAT nuclear translocation (45).
To evaluate the NFAT2 expression and activation, CD8+ 
T lymphocytes from WT mice were purified, left unstimulated, 
or stimulated in vitro with anti-CD3 plus anti-CD28 for differ-
ent times. As expected, TCR stimulation increased both NFAT2 
mRNA and protein level (Figures 1A,B). In unstimulated cells, 
NFAT2 was present in the cytoplasm in an inactive phosphorylated 
form (Figures 1C,D). At 24 h post-activation, we observed NFAT2 
dephosphorylation (Figures 1B,C), and at 48 h post-activation, 
we detected NFAT2 in the nucleus (Figures 1C,D). These data 
show that NFAT2 protein is present and functional in CD8+ 
T lymphocytes.
Development of innate-like cD8+ T cells 
in the absence of nFaT2
To study how NFAT2 regulates CD8+ T cell development and 
responses, we used mice with T cell-specific deficiency in NFAT2. 
We used CD4-cre mice crossed to mice with NFAT2 flanked by 
loxP sites (NFAT2fl/fl). In this model, the NFAT2 gene is excised at 
the DP stage of thymocyte development, affecting both SP CD4 
and CD8 mature T cells. The absence of NFAT2 protein expres-
sion in CD8+ T cells from NFAT2fl/flCD4-Cre mice was confirmed 
by Western blot (Figure 2A).
NFAT2fl/flCD4-Cre mice showed only little changes in total 
cell numbers in the thymus and spleen, but a significant 
decrease of total cell number in lymph nodes (Figure 2B), and 
consistently NFAT2fl/flCD4-Cre mice had reduced size of lymph 
nodes (data not shown). Thymus of NFAT2fl/flCD4-Cre mice 
had similar frequency of DP as well as CD4+ single positive 
FigUre 2 | nFaT2 deficiency increases the frequency of cD8+ T cells. (a) Detection of NFAT2 transcription factor in CD8+ T cells’ total protein lysates 
from WT and NFAT2fl/flCD4-Cre mice by Western blot. (B) Thymus, spleens, and lymph nodes were harvested from WT or NFAT2fl/flCD4-Cre mice, and the total 
number of cells were counted using Trypan blue exclusion. (c) Flow cytometric analysis of thymocytes and total lymph nodes cells from WT or NFAT2fl/fl CD4-Cre 
mice. Shown is the frequency of CD4- and CD8-expressing cells. Right, the percentage of CD4+ and CD8+ cells for all the mice. All results are representative of 
at least two independent experiments. All data are shown as mean ± SD. The ns indicates not significant, *indicates p < 0.05, and **indicates p < 0.01 
compared to WT mice.
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(SP) thymocytes as WT (Figure 2C). Interestingly, there was an 
increase in the frequency of CD8+ SP thymocytes (Figure 2C). 
To examine whether observed difference was thymus-specific 
or a general characteristic, we then analyzed spleen and lymph 
nodes of NFAT2fl/flCD4-Cre mice. The spleen of NFAT2fl/flCD4-
Cre mice had significant reduction of the frequency of total 
T lymphocytes, in particular CD4+, and a slight increase of B 
lymphocytes, while no change was observed for CD8+ T cells 
(data not shown). Lymph nodes of NFAT2fl/flCD4-Cre mice 
showed significantly lower number of CD8+ T lymphocytes in 
NFAT2fl/flCD4-Cre mice compared to WT (data not shown), 
however, with only little changes in the frequency of total 
T  and  B lymphocytes. Similarly, to the spleen, we observed 
a decrease in the frequency of CD4+ T cells (Figure 2C), and 
as seen in the thymus, an increase in the frequency of CD8+ 
T  lymphocytes (Figure 2C).
A higher proportion of CD8+ T cells in the thymus and 
lymph nodes of NFAT2fl/flCD4-Cre mice compared to WT was 
expressing CD44, an activated T cell marker. An increase in the 
frequency of CD8+CD44high cells was also observed in the spleen 
of NFAT2fl/flCD4-Cre mice even without a significant increase in 
the frequency of CD8+ T cells (Figure 3A). As the percentage of 
CD8+CD44high cells was increased in the thymus, lymph nodes, 
and spleen, it suggested that this is not dependent on preferential 
enrichment of these cells in specific tissues.
To exclude the fact that CD8+CD44high T cells are present 
due to an activation, we examined the expression of two activa-
tion markers: CD69 (early activation marker) and CD25 (IL-2 
receptor α-chain). CD8+CD44high population from both WT and 
NFAT2fl/flCD4-Cre mice expressed low and similar percentage of 
CD69+ and CD25+ cells showing that CD8+CD44high population 
is not pre-activated in vivo (Figure 3B).
FigUre 3 | nFaT2 deficiency leads to the development of innate-like cD8+ T cells. (a) Flow cytometric analysis CD8+ T cells for CD44 expression. Right, 
the percentage of CD8+CD44high cells for all the mice. (B) Total CD8+ T cells were analyzed for the expression of CD69, CD25, CD122, CD127, and CD62L. Shown 
are the percentages of T CD8+CD44high populations expressing or not specific surface markers. (c) Total CD8+ T cells were stimulated with PMA plus ionomycin for 
6 h, and cells in CD8+CD44high gate were analyzed for IFN-γ production. Right, the percentage of CD8+CD44highIFN-γ+ cells for all the mice. (D) Total RNA was 
isolated from CD8+CD44high and CD8+CD44low populations from lymph nodes of WT and NFAT2fl/flCD4-Cre mice, and Tbx21 and Eomes mRNA levels were analyzed 
by real-time RT-PCR assay using Taqman probe. The data are normalized to the HPRT levels. All results are representative of at least two independent experiments. 
All data are shown as mean ± SD. The ns indicates not significant, *indicates p < 0.05, and **indicates p < 0.01 compared to WT mice.
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Expression of CD122, the IL-2Rβ chain, has been reported 
to define the population of innate-like CD8+ T cells (46), 
and we found that the CD8+CD44high population in both WT 
and NFAT2fl/fl CD4-Cre mice expressed CD122, although the 
NFAT2fl/flCD4-Cre mice carried larger percentage of these cells 
(Figure 3B).
Moreover, NFAT2fl/flCD4-Cre mice had larger percentage of 
CD8+CD44high CD127+ and CD8+CD44high CD62L+ compared 
7Pachulec et al. NFAT2 in CD8 T Lymphocytes
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to WT (Figure 3B), further showing that CD8+CD44high popula-
tion display conventional memory T cell characteristics without 
previous antigen exposure.
Another characteristic of innate-like CD8+ T cells is the 
rapid production of large amount of IFN-γ upon stimulation 
(16). To determine if these innate-like CD8+ cells exhibit similar 
functional behavior, we analyzed their ability to rapidly secrete 
IFN-γ upon stimulation. Comparison of IFN-γ production by 
PMA plus ionomycin stimulated CD8+CD44high T cells in vitro 
indicated that NFAT2-deficient cells behave similarly to those 
from WT mice in rapid (within 6 h) secretion of this cytokine. A 
similar percentage of the CD8+CD44high T cells responded from 
both WT and NFAT2fl/flCD4-Cre mice (Figure 3C). By contrast, 
CD8+CD44low T cells did not secrete any appreciable IFN-γ in this 
time period (data not shown).
Further analysis of CD8+CD44high population revealed that 
cells from both NFAT2fl/flCD4-Cre and WT mice expressed 
elevated Tbx21 and Eomes mRNA level compared to respective 
CD8+CD44low counterparts. Eomes expression remained similar 
(Figure  3D), while Tbx21 mRNA was reduced without a sig-
nificant difference in CD8+CD44high cells from NFAT2fl/flCD4-Cre 
animals compared to WT.
Taken together, these results demonstrate that NFAT2 
deficiency leads to the development of innate-like CD8+ T cells 
without affecting theirs characteristics, such as surface markers 
and transcription factors expression and IFN-γ production.
nFaT2 Deficiency in T cells results in the 
expansion of PlZF+ T cells
Interleukin-4 is a cytokine classically associated with CD4+ T 
helper type 2 differentiation (47) but has been recently shown 
in different mice models to be also required for the development 
of innate-like CD8+ T lymphocytes through Eomes upregulation 
(9–11, 44, 48–50). To compare the IL-4 production between 
NFAT2fl/flCD4-Cre and WT mice, we stimulated WT and NFAT2-
deficient thymocytes, splenocytes, and total lymph nodes cells ex 
vivo with PMA plus ionomycine for 6 h. We analyzed the produc-
tion of IL-4 by CD3+ cells. We observed that NFAT2fl/flCD4-Cre 
mice had higher percentage of CD3+IL-4+ cells in the thymus and 
lymph nodes and only small increase in the spleen (Figure 4A). 
Consistently, IL-4 mRNA was clearly more abundant in the 
thymus, lymph nodes, and even the spleen of NFAT2fl/flCD4-Cre 
mice (Figure 4B).
In several gene-deficiency models, IL-4 is produced by an 
expanded population of T cells expressing the transcription 
factor PLZF. First, we tested whether NFAT2 absence affects 
the PLZF expression, by measuring the PLZF mRNA expres-
sion in the thymus by real-time PCR. Indeed, we found much 
higher PLZF mRNA level in NFAT2-deficient CD4+ thymocytes 
compared to WT (Figure  4C). Interestingly, in NFAT2fl/flCD4-
Cre mice, we observed the reduction of CD3+ NK1.1+ as 
compared to WT. Further analysis showed that PLZF+ T cell 
population in NFAT2fl/flCD4-Cre mice was NK1.1−, CD4+, 
or CD4− (Figure  4D). Thus, the absence of NFAT2 results in 
the expansion of PLZF+, NK1.1−, CD4+, or CD4− expressing 
T cells and increases the IL-4 production in the thymus and 
the periphery, which, in consequence, may lead to the higher 
frequency of innate-like CD8+ T cells.
The absence of nFaT2 increases the 
Threshold of T cell responses
Nuclear factor of activated T cell transcription factors are 
ubiquitous regulators of gene expression during cellular acti-
vation; however, most reports are focused mainly on CD4+ T 
lymphocytes [for review, see Ref. (23)]. To evaluate the specific 
role of NFAT2 in CD8+ T cell activation, we purified CD8+ T 
lymphocytes from lymph nodes of WT and NFAT2fl/flCD4-Cre 
mice, and we left them either unstimulated or stimulated for 24 
and 48 h with different doses of anti-CD3 plus 1 μg/ml of anti-
CD28. As expected, more than 85% of unstimulated cells were 
positive for CD62L, a protein highly expressed on naive cells, 
and only few expressed CD69 and CD25 activation markers 
(data not shown). TCR stimulation with 1, 0.5, and 0.25 μg/ml 
of anti-CD3 for 24 h led to a reduction of both CD69 and CD25 
expression in NFAT2-deficient cells compared to WT (Figure 5, 
upper panel). The dose of 0.1 μg/ml of anti-CD3 was not suf-
ficient to activate CD8+ T cells (Figure  5). Interestingly, TCR 
stimulation with 1 and 0.5 μg/ml of anti-CD3 for 48 h resulted in 
a similar cell activation as shown by CD69 and CD25 expression 
between WT and NFAT2-deficient cells (Figure 5, lower panel), 
indicating that NFAT2 absence was compensated by another 
transcription factor, likely NFAT1. Only at lower anti-CD3 con-
centration (0.25 μg/ml), the cell activation of NFAT2-deficient 
cells remained significantly reduced in comparison to WT 
(Figure 5, lower panel), indicating that the absence of NFAT2 
increases the threshold of CD8+ T cell activation at suboptimal 
TCR stimulation.
As NFAT2 deficiency in CD8+ T cells increased the threshold 
of T cell activation, we next tested the effect of NFAT2 absence 
on CD8+ T cell proliferation. Purified CD8+ T cells were stained 
with CFSE and then activated for different times with 0.25 μg/ml 
anti-CD3 plus 1  μg/ml of anti-CD28. At indicated times, cell 
proliferation was monitored by flow cytometric measurement 
of CFSE dye dilution. Low concentration of anti-CD3 led to a 
reduced proliferation of NFAT2-deficient CD8+ T cells with divi-
sion indexes of 3.19 for WT and 2.64 for NFAT2-deficient cells 
after 72 h, indicating that NFAT2 absence increases the threshold 
of triggering CD8+ T cell into division (Figure 6A).
Consistent with defects in cell activation and proliferation, 
NFAT2-deficient CD8+ T cells were also weak producers of 
both IFN-γ and IL-2. The slight difference was observed even 
at strong TCR stimulation, but clear decrease of the percentage 
of IFN-γ- and IL-2-producing cells was observed at suboptimal 
dose of anti-CD3 (Figure 6B). Next, we decided to determine 
whether defect of IL-2 production in NFAT2-deficient CD8+ 
T cells results in delayed cell proliferation. Purified CD8+ T cells 
were stained with CFSE and then activated for different times 
with 0.25  μg/ml anti-CD3 plus 1  μg/ml of anti-CD28 in the 
absence or presence of 200 U/ml of IL-2. At indicated times, cell 
proliferation was monitored by flow cytometric measurement of 
CFSE dye dilution. Addition of IL-2 restored the proliferation 
of NFAT2-deficient CD8+ T cells at 48 h (data not shown) and 
FigUre 4 | expansion of PlZF expressing cells in the absence of nFaT2. Total thymocytes, splenocytes, and lymph nodes cells were stimulated with PMA 
plus ionomycin for 6 h. IL-4-producing cells were analyzed in CD3+ gate. Right, the percentage of CD3+IL-4+ cells for all the mice (a). Total RNA was isolated from 
thymus, spleen, and lymph nodes from WT and NFAT2fl/flCD4-Cre mice, and IL-4 mRNA levels were analyzed by real-time RT-PCR assay using Taqman probe. The 
data are normalized to the HPRT levels (B). Total RNA was isolated from CD4+ thymocytes and analyzed for PLZF mRNA level by real-time RT-PCR using 
SyberGreen. The data are normalized to the actin levels (c). Flow cytometric analysis of CD3+, CD4+, and NK1.1+ thymocytes for PLZF expression (D). All results 
are representative of at least two independent experiments. All data are shown as mean ± SD. The ns indicates not significant, *indicates p < 0.05, and **indicates 
p < 0.01 compared to WT mice.
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FigUre 5 | nFaT2 absence increases the threshold of cD8+ T cells activation. Total lymph nodes cells from WT and NFAT2fl/flCD4-Cre mice were activated 
for 24 and 48 h with different doses of anti-CD3 and 1 μg/ml of anti-CD28. Cells in CD8+ gate were analyzed for the expression of CD69 and CD25. All data are 
representative of at least three independent experiments.
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72  h post-activation (Figure  6C) demonstrating that reduced 
proliferation in the absence of NFAT2 is due to decreased IL-2 
secretion.
nFaT2 regulates iFn-γ Production by 
cytotoxic cD8+ T cells
Antigen-induced CD8+ T cells differentiate into cytotoxic CD8+ 
T cells (CTLs) that kill infected cells and release cytokines, 
such as IFN-γ (1). To analyze if NFAT2-deficient CD8+ T cells 
have any other intrinsic defects besides increased threshold of 
activation, proliferation, and cytokine secretion, we determined 
if differentiation and function of CTLs in vitro were intact. To 
differentiate CTLs in vitro, we followed as reported (43). Briefly, 
purified CD8+ T cells from WT and NFAT2fl/flCD4-Cre mice were 
stimulated for 48  h with 1 μg/ml of anti-CD3 plus anti-CD28 
and expanded daily with murine recombinant IL-2 (200 U/ml) 
(Figure  7A). At day 5, cells were collected and analyzed. The 
WT cytotoxic CD8+ T cells differentiated in  vitro showed a 
downregulation of NFAT2 mRNA expression compared to 
naive CD8+ T cells (Figure 7B). No significant difference in cell 
viability and proliferation between WT and NFAT2-deficient 
CTLs was observed using the Trypan blue exclusion method 
(Figure  7C). The expression of activation markers, CD44 and 
CD25, was also comparable between WT and NFAT2-deficient 
CTLs (Figure  7D), indicating that NFAT2 does not influence 
either proliferation or activation of cytotoxic CD8+ T cells.
FigUre 6 | nFaT2 deficiency increases the threshold of cD8+ T cells proliferation and cytokines production. (a) CD8+ T cells from lymph nodes of WT 
and NFAT2fl/flCD4-Cre mice were purified, stained with CFSE as described, and activated with 0.25 μg/ml of anti-CD3 plus 1 μg/ml of anti-CD28 for indicated times. 
At each time point, CFSE dye dilution was analyzed by flow cytometry. (B) CD8+ T cells from lymph nodes of WT and NFAT2fl/flCD4-Cre mice were purified and 
activated for 48 h with either 1 or 0.25 μg/ml of anti-CD3 plus 1 μg/ml of anti-CD28. Then, cells were restimulated with PMA plus ionomycin for 6 h, and intracellular 
IL-2 and IFN-γ production was analyzed by flow cytometry. Shown is the percentage of IL-2- and IFN-γ-expressing cells. (c) CD8+ T cells from lymph nodes of WT 
and NFAT2fl/flCD4-Cre mice were purified, stained with CFSE as described, and activated with 0.25 μg/ml of anti-CD3 plus 1 μg/ml of anti-CD28 in the absence or 
presence of 200 U/ml IL-2 for indicated times. At each time point, CFSE dye dilution was analyzed by flow cytometry. All data are representative of at least two 
independent experiments.
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CD8+ T cytotoxic activity was measured as the ability to 
effectively lyse P815 cells. NFAT2-deficient CTLs had slightly 
reduced potential to lyse P815 cells at 1:1 and 1:2 effector:target 
ratios (Figure  7E). Consistently, granzyme B expression was 
slightly decreased without statistical significance in NFAT2-
deficient CTLs (Figure 7F). Remarkably, NFAT2-deficient CTLs 
produced significantly less IFN-γ compared to their proficient 
counterparts (Figure 7F).
Transcription factors T-bet and Blimp-1 are reported to play 
a crucial role in promoting cytotoxic CD8+ T cell differentia-
tion (51, 52); therefore, we tested what is the effect of NFAT2 
absence in CTLs on the expression of T-bet and Blimp-1. 
FigUre 7 | iFn-γ production by cytotoxic cD8+ T cells is regulated by nFaT2. (a) Schematic representation of cytotoxic CD8+ T cell differentiation in vitro. 
Purified CD8+ T cells from WT and NFAT2fl/flCD4-Cre mice were differentiated in vitro into cytotoxic CD8+ T lymphocytes as described. (B) Total RNA isolated from 
naive CD8+ T cells (NAIVE) or from in vitro differentiated cytotoxic CD8+ T lymphocytes (CTLs) were analyzed for NFAT2 mRNA levels by real-time RT-PCR assay 
using SYBR green master mix. The data are normalized to the β-actin levels. (c) Total number of live WT and NFAT2-deficient CD8+ T lymphocytes was recorded 
daily during in vitro differentiation using Trypan blue exclusion method. (D) Flow cytometric analysis of CD44 and CD25 expression on differentiated cytotoxic WT 
and NFAT2-deficient CD8+ T cells at day 5. The analysis of MFI from three independent experiments on the right. (e) At day 5, differentiated cytotoxic CD8+ T cells 
were tested in cytotoxicity assay against P815 cells as described at indicated efector:target ratios or restimulated with PMA plus ionomycin for 6 h, and intracellular 
granzime B and IFN-γ production was analyzed by flow cytometry. The analysis of MFI from three independent experiments on the right (F). (g) Total RNA was 
isolated from differentiated in vitro WT and NFAT2-deficient cytotoxic CD8+ T lymphocytes, and T-bet and Blimp-1 mRNA levels were analyzed by real-time RT-PCR 
assay using Taqman probes. The data are normalized to the HPRT RNA levels. All data are shown as mean ± SD of three independent experiments. The ns 
indicates not significant and *indicates p < 0.05 compared to WT mice.
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NFAT2-deficient CTLs had lower expression of both T-bet 
and Blimp-1, although in both cases, the difference remained 
insignificant (Figure 7G).
Taken together, these data demonstrate that NFAT2 does 
not significantly affect the differentiation of CD8+ T cells into 
cytotoxic T cells but positively controls the IFN-γ production.
DiscUssiOn
In this study, we characterized the role of NFAT2 in CD8+ T cell 
development and responses. During analysis of mice lacking 
NFAT2 in T cells, we noted that these mice in comparison to 
WT mice had an increased percentage of CD8+CD44highCD122+ 
cells in the thymus, spleen, and lymph nodes. Upon stimula-
tion with PMA plus ionomycine, CD8+CD44high cells rapidly 
produced IFN-γ; however, in the same manner as WT 
CD8+CD44high indicating that NFAT2 is not essential for 
IFN-γ production. Rapid IFN-γ production by stimulated 
naive CD8+ T cells was reported to be dependent on NFAT1 
(53), thus NFAT2 seems only to regulate the development of 
CD8+CD44highCD122+ cells.
CD8+CD44highCD122+ population is known as innate-like 
CD8+ T cells, has the phenotype of memory CD8+ T cells, and 
function as innate cells. In contrast to the so-called “true” or 
“conventional” memory cells that are induced by TCR stimula-
tion with foreign antigen, this population is present in a steady 
state without contact with the foreign antigen. There have been 
numerous studies that have investigated innate-like cells in 
different experimental contexts. Mice deficient in or expressing 
mutant forms of diverse T-cell signaling molecules or transcrip-
tion factors, including the scaffold protein SLP-76 (54), Itk (7, 
55), the transcription factor KLF2 (Kruppel-like factor 2) (13, 
44), the histone acetyltransferase CBP (CREB-binding protein), 
and the transcriptional regulator Id3 (inhibitor of DNA-binding 
3) (12), also display an increased frequency and numbers of 
innate-like CD8+ T cells [reviewed in Ref. (56)]. Similar popula-
tion of CD8+CD44high cells have been reported in mice lacking 
classical class I molecules, and this phenotype appears to be 
class 1b restricted (7, 57). Together, the similar phenotypes of 
these different mouse strains define a network of diverse effector 
proteins involved in a TCR signaling pathway to gene expres-
sion, which together specify increased generation of innate-like 
CD8+ T cells.
Based on the origin, CD8+CD44high cells are grouped in two 
populations. The first is called homeostatic memory or virtual 
memory that arises both in the lymphopenia and physiological 
environment in the periphery, in an IL-15-dependent manner 
(58). CD8+CD44high cells appear upon the transfer of naive 
T cells into lymphopenic mice (44). Consistently, patients 
recovering from bone marrow transplant, older people, and 
mice also showed elevated percentages of T cells with a similar 
phenotype (59–61). In addition, viral and other infections 
can lead to expanded populations of T cells bearing this 
phenotype (19).
The second group is IL-4-induced memory cells or innate-like 
CD8+ T cells identified in gene-deficient or mutant mice and 
also in normal mice (62). A common feature of these mice is the 
expansion of one or more subsets of PLZF+ thymocytes secret-
ing  IL-4, which in turn drive the expansion of the innate-like 
CD8+ T cells in a cell-extrinsic manner (10, 11, 44, 48). PLZF+ 
cells are rare or not activated to produce IL-4 in WT mice; how-
ever, distinct genetic alterations influence their generation and 
activation, and consequently increase innate-like CD8+ T cells 
presence. We show that NFAT2 deficiency in T cells results 
in the expansion of PLZF+ NK1.1−CD4+ and CD4− T cells. 
Consistently, we also observed increased IL-4 mRNA and IL-4 
production by CD3+ cells in the thymus, spleen, and lymph 
nodes of NFAT2fl/flCD4-Cre mice. Therefore, innate-like CD8+ 
T cells development in NFAT2fl/flCD4-Cre mice seem to also be 
IL-4 dependent. To explain how NFAT2 exactly regulates the 
development of PLZF+ thymocytes and IL-4 production by those 
cells, further investigation is required.
Both virtual memory and innate CD8+ T cells are pheno-
typically and functionally very similar. They differ in cytokine 
dependence, IL-15 for virtual memory, and IL-4 for innate-like 
CD8+; origin, arising in the periphery vs. thymus, respectively, 
and differential expression profile of certain genes, such as 
Tnfarsf1a, Nfkb2, Eomes, and Bcl2l11 (63). Interestingly, virtual 
memory CD8+ T cells were also reported to develop in the 
presence of IL-4 overproduction in the periphery (64). It is 
still unclear whether these cell populations represent different 
subsets of alternative memory CD8+ T cells or if they are the 
same cell population that acquired its phenotype with different 
pathways. If we claim two distinct populations of alternative 
memory CD8+ T cells, it is possible that CD8+CD44high popula-
tion in NFAT2fl/flCD4-Cre mice is heterogeneous and is com-
prised of both innate-like CD8+ T cells developed in the thymus 
and virtual memory CD8+ T cells developed in the periphery, 
both in IL-4-dependent manner.
In the absence of NFAT2, CD8+ T cells showed increased 
threshold for activation, proliferation, and cytokines production 
under suboptimal TCR stimulation. The fact that CD69 and 
CD25 activation markers were strongly reduced at 24  h post-
activation and then at 48 h post-activation were similar to WT 
level indicates that NFAT2 deficiency has been compensated 
by other transcription factor, likely NFAT1. Only at suboptimal 
TCR stimulation, NFAT2 was crucial for complete CD8+ T cell 
responses.
Nuclear factor of activated T cells 2 deficiency resulted as 
well in the reduced capacity of CD8+ T cells to proliferate under 
suboptimal anti-CD3 concentration. Previous studies using 
NFAT2−/−/Rag-1−/− chimeric mice likewise reported impaired 
proliferation of NFAT2-deficient T cells (38) but indepen-
dently of autocrine IL-2 secretion. In the EAE model, NFAT2 
deficiency reduced the proliferation capacity of MOG-specific 
T cells in IL-2-dependent and -independent manners (41). 
In our model, CD8+ T cells produced less IL-2 under suboptimal 
TCR stimulation, and NFAT2 deficiency reduced proliferation 
in IL-2-dependent manner.
Nuclear factor of activated T cells 2 is not required for the 
cytotoxic activity of CD8+ T cells in vitro but appears to be impor-
tant for their IFN-γ production. IFN-γ production by cytotoxic 
CD8+ T cells is regulated by T-bet and Blimp-1 transcription 
factors. There was only a slight decrease in T-bet expression but 
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clear reduction of Blimp-1 expression in the absence of NFAT2. 
Whether NFAT2 influences the IFN-γ expression by directly 
binding to the IFN-γ promoter or the reduction of IFN-γ protein 
expression is secondary to the downregulation of Blimp-1, and/or 
T-bet transcription factors have to be further investigated. Similar 
defect in IFN-γ production was also found in CD8+ T cytotoxic 
cells in EAE model in  vivo (41). NFAT2−/−/Rag-1−/− chimeric 
mice developed comparable cytotoxic T lymphocyte responses 
to the virus indicating that NFAT2 is not essential for the helper 
function in vivo (38).
In conclusion, we demonstrate in this study that NFAT2 is 
involved in several aspects of CD8+ T cell biology. In regard to 
T cell development, NFAT2 is a negative regulator of innate-
like CD8+ T cells and PLZF+ expressing T cells development. 
What concerns CD8+ T cell responses upon TCR stimulation, 
we show that the absence of NFAT2 increases the threshold of 
CD8+ T cell activation and decreases IFN-γ and IL-2 production 
and thus delays cell proliferation in an IL-2-dependent manner. 
Furthermore, we show that although NFAT2 does not impact 
cytotoxic CD8+ T cells differentiation in vitro, it is clearly required 
for IFN-γ production. Finally, we show that NFAT2 regulates 
both innate immune response via innate-like CD8+ T cells and 
adaptive immune response by controlling IFN-γ production by 
effector CD8+ T lymphocytes.
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